NAPWA

Historically, HIV disease has been associated with changes to body shape. read more »

The Commonwealth’s recent decision to list Sculptra on the PBS[Pharmaceutical Benefits Scheme[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs.] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs. is exciting news for Australia’s positive community. Anyone with HIV treatment­associated facial lipoatrophy is now subsidised to receive up to eight vials for their first treatment followed by top­ups of two vials every two years read more »

Today’s PBS[Pharmaceutical Benefits Scheme[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs.] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs. listing of a treatment for HIV-associated facial wasting will provide substantial improvements in quality of life for people living with HIV, the National Association of People Living with HIV/AIDS (NAPWA) has said. read more »

Viral loadA measurement of the quantity of HIV RNA in the blood. Viral load blood test results are expressed as the number of copies (of HIV) per milliliter of blood plasma. and CD4 cell count results are two of the main tests used to inform treatment decisions about starting or changing treatments. Usually every time you have regular blood tests a whole range of other tests are done. Some of these are useful in monitoring for possible drug side effects and potential organ damage. read more »

Doctor Louise Owen answers readers’ questions. This month: starting antiretroviralA medication or other substance which is active against retroviruses such as HIV. treatment and lipodystrophy. read more »

People with severe facial lipoatrophy caused by HIV treatments are closer to being able to access subsidised treatment with poly-lactic acid under the Pharmaceutical Benefits Scheme[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs. (PBS). read more »

People with facial lipoatrophy are eagerly awaiting the decision by the Pharmaceutical Benefits Advisory Committee to have the facial filler, Sculptra, listed on the Pharmaceutical Benefits Scheme[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs.. read more »

From Treat Yourself Right, this article explains lipodystrophy (the unusual or abnormal distribution of fat throughout your body) from a positive woman's perspective. Includes strategies for management. read more »

The listing of two new HIV treatment options on the Pharmaceutical Benefits Scheme[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs. (PBS) is good news for people living with HIV, the National Association of People Living with HIV/AIDS (NAPWA) has said. read more »

A possible new treatment for excessive abdominal fat associated with HIV-related lipodystrophy was presented at IAS 2008. read more »